Credit Suisse Ag Bluebird Bio, Inc. Put Options Transaction History

Credit Suisse Ag

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 16, 2021	BUY	$18.04 - $22.09 $517,748 - $633,983	28,700 Added 64.79%	73,000 $2.34 Million
Q1 2021 May 14, 2021	SELL	$16.59 - $33.89 $3.34 Million - $6.82 Million	-201,300 Reduced 81.96%	44,300 $1.34 Million
Q4 2020 Feb 12, 2021	BUY	$27.5 - $37.92 $1.16 Million - $1.59 Million	42,000 Added 20.63%	245,600 $10.6 Million
Q3 2020 Nov 13, 2020	BUY	$34.44 - $43.75 $6.6 Million - $8.38 Million	191,500 Added 1582.64%	203,600 $11 Million
Q2 2020 Aug 12, 2020	SELL	$27.12 - $45.97 $9.12 Million - $15.5 Million	-336,100 Reduced 96.52%	12,100 $739,000
Q3 2019 Nov 12, 2019	BUY	$59.47 - $93.1 $20.7 Million - $32.4 Million	348,200 New	348,200 $32 Million

42.6M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $466M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.